Methyldopa And Hydrochlorothiazide


Methyldopa And Hydrochlorothiazide

Drug - Methyldopa And Hydrochlorothiazide
The trade name of the product as shown on the labeling.

The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Hydrochlorothiazide; Methyldopa
Multiple ingredients are in alphabetical order.

Strength - 50MG;500MG
The potency of the active ingredient(s), Hydrochlorothiazide; Methyldopa. May repeat for multiple part products.

Applicant - TEVA
The firm name holding legal responsibility for Methyldopa And Hydrochlorothiazide. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 071822
The FDA assigned number to Methyldopa And Hydrochlorothiazide. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Methyldopa And Hydrochlorothiazide. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Apr 8, 1988
The date Methyldopa And Hydrochlorothiazide was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Methyldopa And Hydrochlorothiazide. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Methyldopa And Hydrochlorothiazide is in. Format is RX, OTC, DISCN.

Applicant Full Name - Teva Pharmaceuticals Usa Inc
The full name of the firm holding legal responsibility for the new application of Methyldopa And Hydrochlorothiazide.

Methyldopa And Hydrochlorothiazide